![[up]](/style/images/multi_up.png)
Up a level2025
Richardson, Tim 
ORCID: 0009-0006-3588-6376, Holtick, Udo ORCID: 0000-0002-5543-0257, Frenking, Jan-Hendrik ORCID: 0009-0001-9682-2601, Tharmaseelan, Hishan ORCID: 0009-0002-5680-8714, Balke-Want, Hyatt ORCID: 0000-0002-5963-7626, Flümann, Ruth ORCID: 0000-0002-7147-7557, Mai, Elias Karl ORCID: 0000-0002-6226-1252, Sauer, Sandra, Teipel, Raphael ORCID: 0000-0002-9985-6583, von Bonin, Malte ORCID: 0000-0002-2995-3230, Hallek, Michael ORCID: 0000-0002-7425-4455, Scheid, Christof ORCID: 0009-0007-6539-226X and Gödel, Philipp ORCID: 0000-0001-7887-8313
(2025).
Sequential BCMA CAR T-cell therapy in refractory multiple myeloma.
Blood Advances, 9 (18).
pp. 4624-4630.
Elsevier.
ISSN 2473-9529
Richardson, Tim ORCID: 0009-0006-3588-6376, Schütte, Daniel ORCID: 0000-0002-4746-537X, Kobbe, Guido, Baermann, Ben-Niklas, Holderried, Tobias A. W. ORCID: 0000-0002-2474-523X, Schmitz, Friederike ORCID: 0000-0002-5271-1088, Crysandt, Martina, Hallek, Michael ORCID: 0000-0002-7425-4455, Scheid, Christoph ORCID: 0009-0007-6539-226X, Holtick, Udo ORCID: 0000-0002-5543-0257, Cornely, Oliver A. ORCID: 0000-0001-9599-3137, Stemler, Jannik ORCID: 0000-0001-9152-2469 and Mellinghoff, Sibylle C. ORCID: 0000-0003-3928-2503
(2025).
Characteristics of infections after BCMA-directed CAR T-cell therapy for multiple myeloma: a real-world analysis.
Blood Advances, 9 (6).
pp. 1370-1375.
Elsevier.
ISSN 2473-9529